A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
AC079354.1 | Uncharacterized protein KIAA2012 | | | | | | Tissue enriched |
ACTL6B | Actin-like 6B | | | | | | Tissue enriched |
ACTL7A | Actin-like 7A | Cytoskeleton related proteins
| | | | | Tissue enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADIRF | Adipogenesis regulatory factor | Plasma proteins
| | | | | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | | | | | | Tissue enhanced |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | | | | | | Tissue enhanced |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |
AIM1L | Absent in melanoma 1-like | | | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
AKNAD1 | AKNA domain containing 1 | | | | | | Tissue enhanced |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | Enzymes
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALX1 | ALX homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
ANKRD1 | Ankyrin repeat domain 1 (cardiac muscle) | Disease related genes
| | | | | Tissue enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
ANKRD23 | Ankyrin repeat domain 23 | | | | | | Tissue enriched |
ANKRD34A | Ankyrin repeat domain 34A | | | | | | Tissue enriched |
ANLN | Anillin, actin binding protein | | | | | | Tissue enhanced |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | | | | | | Tissue enhanced |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
ARHGAP28 | Rho GTPase activating protein 28 | | | | | | Tissue enhanced |
ARHGAP40 | Rho GTPase activating protein 40 | | | | | | Group enriched |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | | | | | | Tissue enhanced |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | Transcription factors
| | | | | Tissue enhanced |
ARMC4 | Armadillo repeat containing 4 | Disease related genes
| | | | | Group enriched |
ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Transcription factors
| | | | | Tissue enhanced |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | | | Tissue enhanced |